Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
10
XXII Quote, Financials, Valuation and Earnings
Last price:
$5.01
Seasonality move
:
-2.66%
Day range:
$4.61 - $5.28
52-week range:
$3.90 - $581.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.01x
P/B ratio:
0.79x
Volume:
101.6K
Avg. volume:
91K
1-year change:
-98.83%
Market cap:
$2.7M
Revenue:
$32.2M
EPS (TTM):
-$8,358.46
Earnings Data
Next earnings date for XXII
Mar 28
2025
Most recent earnings per share
-$74.25
Missed by $74.25
(Nov 12/2024)
Consensus Estimate
--
(Nov 12/2024)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
XXII Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 11/12/2024 | Q3 | -- | $2.5M | -$74.25 | -- | -- |
| 08/13/2024 | Q2 | -- | $4.4M | -$28.35 | -- | -- |
| 05/15/2024 | Q1 | $7.9M | $3.1M | -$6,350.40 | -- | -- |
| 03/28/2024 | Q4 | $18.7M | $19.7M | -$1,905.46 | -- | -- |
| 11/06/2023 | Q3 | -- | -- | -$8,201.25 | -$2,073.60 | -$6,127.65 |
| 08/14/2023 | Q2 | -- | -- | -$3,214.35 | -$2,268.00 | -$946.35 |
| 05/09/2023 | Q1 | -- | -- | -$2,714.14 | -$2,430.00 | -$284.14 |
| 03/09/2023 | Q4 | -- | -- | -$3,888.00 | -$1,944.00 | -$1,944.00 |
| 11/08/2022 | Q3 | -- | -- | -$2,030.40 | -$1,944.00 | -$86.40 |
| 08/09/2022 | Q2 | -- | -- | -$2,051.99 | -$1,863.00 | -$188.99 |
| 05/05/2022 | Q1 | -- | -- | -$1,620.00 | -$2,592.00 | $972.00 |
| 03/01/2022 | Q4 | -- | -- | -$2,916.00 | -- | -- |
| 11/04/2021 | Q3 | -- | -- | -$1,944.00 | -- | -- |
| 08/05/2021 | Q2 | -- | -- | -$972.00 | -- | -- |
| 05/06/2021 | Q1 | -- | -- | -$972.00 | -- | -- |
| 03/11/2021 | Q4 | -- | -- | -$1,296.00 | -- | -- |
| 11/05/2020 | Q3 | -- | -- | -$972.00 | -- | -- |
| 08/06/2020 | Q2 | -- | -- | -$1,296.00 | -- | -- |
| 05/07/2020 | Q1 | -- | -- | -$972.00 | -- | -- |
| 12/31/2019 | Q4 | -- | -- | -$1,620.00 | -- | -- |
| 09/30/2019 | Q3 | -- | -- | -$2,592.00 | -- | -- |
| 06/30/2019 | Q2 | -- | -- | -$1,944.00 | -- | -- |
| 03/31/2019 | Q1 | -- | -- | -$648.00 | -- | -- |
| 12/31/2018 | Q4 | -- | -- | -$2,268.00 | -- | -- |
| 11/07/2018 | Q3 | -- | -- | $1,296.00 | -- | -- |
| 06/30/2018 | Q2 | -- | -- | -$1,620.00 | -- | -- |
| 03/31/2018 | Q1 | -- | -- | $324.00 | -- | -- |
| 12/31/2017 | Q4 | -- | -- | -$972.00 | -- | -- |
| 09/30/2017 | Q3 | -- | -- | -$972.00 | -- | -- |
| 06/30/2017 | Q2 | -- | -- | -$1,296.00 | -- | -- |
| 05/08/2017 | Q1 | -- | -- | -$972.00 | -- | -- |
| 03/09/2017 | Q4 | -- | -- | -$1,296.00 | -- | -- |
| 11/09/2016 | Q3 | -- | -- | -$972.00 | -- | -- |
| 08/10/2016 | Q2 | -- | -- | -$1,296.00 | -- | -- |
| 05/09/2016 | Q1 | -- | -- | -$1,296.00 | -- | -- |
| 03/11/2016 | Q4 | -- | -- | -$1,296.00 | -- | -- |
| 11/13/2015 | Q3 | -- | -- | -$1,296.00 | -- | -- |
| 08/05/2015 | Q2 | -- | -- | -$648.00 | -- | -- |
| 05/15/2015 | Q1 | -- | -- | -$1,944.00 | -- | -- |
| 02/05/2015 | Q4 | -- | -- | -$2,916.00 | -- | -- |
22nd Century Group Earnings Questions
-
How Much did 22nd Century Group Generate in Revenue Last Quarter?
22nd Century Group reported $2.5M worth of top line sales in its most recent quarter.
-
Did 22nd Century Group Beat Earnings Last Quarter?
22nd Century Group announced earnings per share of -$74.25 which represents a miss of analyst forecast a -- per share.
-
Is 22nd Century Group Profitable?
22nd Century Group reported -$588K that represents -$5.88 per share over the last quarter.
-
What is the Analyst Consensus for 22nd Century Group EPS Next Year?
22nd Century Group's earnings are forecast to decrease from -$15,724.80 per share to -- per share next year representing a decrease of -7.31%.
-
When is 22nd Century Group's Earnings Date?
22nd Century Group's next earnings date is March 28, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 1.47% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 10% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 1.24% over the past day.
